Health

GPs report a shortage of flu vaccine on 22 November

GP surgeries in Germany are having to postpone vaccination appointments, according to their association. The Paul Ehrlich Institute, however, says there is no nationwide supply shortage.

GP surgeries in Germany are having difficulty obtaining enough flu vaccine . As reported on 22 November 2026, affected practices are therefore having to postpone vaccination appointments. The Paul Ehrlich Institute says there is no nationwide supply shortage, according to a spokesperson.

The federal chair of the Association of General Practitioners, Nicola Buhlinger-Göpfarth, told the Augsburger Allgemeine that some deliveries had arrived late or in smaller quantities than ordered. Problems were particularly acute with vaccines for people over 60. Practice staff sometimes had to contact several pharmacies to obtain doses. The association says this is disrupting the vaccination campaign.

The Paul Ehrlich Institute confirmed to the newspaper that testing and approval of vaccine batches had started later this year. The institute’s spokesperson did not infer from this that there was a nationwide shortage. The Federal Association of German Pharmacists’ Associations also told the newspaper that supplies were generally secure, even if individual products might temporarily be out of stock.

These statements describe different levels of supply: an adequate overall quantity does not necessarily mean that a particular product will be available at every practice by the agreed appointment. The published information does not say how many practices are affected or how long individual patients may have to wait.

The Paul Ehrlich Institute had already announced on 27 August 2026 that it had tested and approved the first batches for the 2026/2027 season. Government batch approval is one step before vaccines can be used; the number of batches alone does not show how much was delivered to individual practices.

The Association of General Practitioners also criticises the way orders are planned. Practices have to register their requirements many months in advance, Buhlinger-Göpfarth said. At that point, it is difficult to estimate how many people will later seek vaccination. If too little is ordered, obtaining additional supplies can be difficult; if too much is ordered, there is a risk of financial losses. The association is therefore calling for political action.

The Standing Committee on Vaccination recommends annual influenza vaccination for, among others, people aged 60 and over, those with chronic illnesses, pregnant women and medical staff. According to information from the Robert Koch Institute it should ideally be given between October and mid-December, so that protection can build up in time. Availability at practices is therefore particularly important for people at increased risk of severe illness.

Former federal health minister Karl Lauterbach said on 22 November that, in his assessment, Germany had enough vaccine. His assessment and the institute’s statements do not necessarily contradict reports of shortages at local practices. It remains unclear whether, and how quickly, the affected practices will be able to replenish their stocks.

Editor: Clara Simonichek (Article created with AI assistance).

Sources